Skip to main content
Clinical Trials/IRCT2017030432871N1
IRCT2017030432871N1RecruitingPhase 1

Study to Evaluate Efficacy and Safety of Sumatriptan and Ondansetron for the Treatment of Intrathecal Fentanyl-Induced Pruritus in Patients Undergoing Spinal Anesthesia

Brain and Spinal Cord Injury Research Center0 sites75 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Males or females who are at least 18 years and no more than 65 years of age; Candidate for urologic, gynecologic or general surgery with spinal anesthesia, Intrathecal fentanyl-induced pruritus; Giving informed consent; ASA physical status I-II; GCS equal to 15;
  • Exclusion criteria: Pruritus secondary to a pruritic skin disease or systemic disorder; Topical or systemic treatments which may affect the intensity of itch; History of cardiovascular diseases, or uncontrolled serious systemic disorders; Currently is taking a monoamine oxidase inhibitor (MAO) or has taken a MAOI within the 2 weeks prior to screen; Currently is taking an ergotamine-containing medication; Being pregnant, actively trying to become pregnant or breastfeeding; Alcohol or substance abuse

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Brain and Spinal Cord Injury Research Center

Similar Trials